Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636389 · ClinicalTrials.gov registry record · NA
Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers
A NA study, sponsored by Vantive Health.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00636389 is a NA study that has completed, run by Vantive Health. The registered enrollment target is 12 participants.
The verdict
NCT00636389, a NA study, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and, 2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.
Interventions
- DEVICE Polyflux 210H dialyzer
- DEVICE Polyflux HD-C4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00636389
The ClinicalTrials.gov registry entry for NCT00636389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polyflux 210H dialyzer is the first listed.
NCT00636389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00636389 about?
NCT00636389 is a clinical study titled "Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers". The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and lar...
What is the current status of trial NCT00636389?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2008-02. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00636389?
The interventions under investigation include: Polyflux 210H dialyzer (DEVICE), Polyflux HD-C4 (DEVICE).
Who is sponsoring clinical trial NCT00636389?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.